Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.

Journal: Cancer Cell

Published: 2020-01-13

DOI: 10.1016/j.ccell.2019.12.003

Affiliations: 9

Authors: 19

Go to article
Institutions Share
Randall Centre of Cell and Molecular Biophysics, KCL, United Kingdom (UK) 0.31
Barts Cancer Institute (BCI), QMUL, United Kingdom (UK) 0.20
NIHR Guy's and St Thomas' Biomedical Research Centre, United Kingdom (UK) 0.13
Tumour-Host Interaction Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.12
Cancer Research UK Cancer Therapeutics Unit, United Kingdom (UK) 0.05
Molecular Oncology Group, UoM, United Kingdom (UK) 0.05
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.05
UCL Cancer Institute, United Kingdom (UK) 0.05
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.03

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER